Showing results (211-220 of 1,155) with videos related to

Sort By:
Pageof 116
Blood|February 21, 2009
Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targetingAntonina V Kurtova, Archito T Tamayo, Richard J Ford, et al.
Radiation Oncology (London, England)|June 2, 2018
Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancerChristian Britschgi, Oliver Riesterer, Irene A Burger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasionSamuel S Im, Sharon P Wilczynski, Robert A Burger, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1976
The failure of physiologic doses of reverse T3 to effect thyroid-pituitary function in manP Nicod, A Burger, G Strauch, et al.
Clinical Nuclear Medicine|April 29, 2016
Ovarian Hyperstimulation and Oocyte Harvesting Prior to Systemic Chemotherapy-A Possible Pitfall in 18F-FDG PET/CT Staging of Oncologic PatientsSara Bacanovic, Ruth Stiller, Magdalena Pircher, et al.
Acta Medica Scandinavica|January 1, 1977
Divergent changes of serum 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine in patients with acute myocardial infarctionU Westgren, A Burger, K Levin, et al.
International Immunopharmacology|June 16, 2001
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected miceR W Sidwell, D F Smee, K W Bailey, et al.
Acta Endocrinologica|September 1, 1975
Radioimmunoassays of 3,5,3'-triiodo-L-thyronine with and without a prior extraction stepA Burger, C Sakoloff, V Staeheli, et al.
MDM Policy & Practice|January 13, 2022
Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in NorwayAllison Portnoy, Mari Nygård, Lill Trogstad, et al.
BMC Cancer|May 9, 2019
The healthcare costs of treating human papillomavirus-related cancers in NorwayHannah Hylin, Helene Thrane, Kine Pedersen, et al.
Pageof 116